DC
LLY icon

Dahring Cusmano’s Eli Lilly LLY Stock Holding History

Dahring Cusmano’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$684K Buy
571
+253
+80% +$258K 0.36% 35
2026
Q1 		$293K Hold
318
– – 0.18% 51
2025
Q4 		$342K Sell
318
-49
-13% -$46.9K 0.24% 40
2025
Q3 		$280K Buy
367
+5
+1% +$3.72K 0.2% 47
2025
Q2 		$282K Buy
362
+7
+2% +$5.44K 0.22% 44
2025
Q1 		$293K Buy
355
+5
+1% +$4.16K 0.25% 41
2024
Q4 		$270K Buy
+350
New +$290K 0.24% 46

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dahring Cusmano's LLY Position: Q2 2026 in Review

Dahring Cusmano increased its Eli Lilly (LLY) stake by 80% in Q2 2026, buying an estimated $258K and bringing the position to 571 shares worth $684K. The position accounts for 0.36% of the portfolio, ranked #35.

Dahring Cusmano first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dahring Cusmano held 571 shares of Eli Lilly worth $684K as of Q2 2026.
  • Dahring Cusmano bought 253 Eli Lilly shares in Q2 2026, an estimated $258K.
  • Eli Lilly made up 0.36% of Dahring Cusmano's portfolio in Q2 2026, its #35 holding.
  • Dahring Cusmano first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dahring Cusmano's 13F filing for Q2 2026, filed 28 Jul 2026.